Diagnosis and management of secondary-progressive multiple sclerosis: time for change
J Oh, K Alikhani, T Bruno, V Devonshire… - Neurodegenerative …, 2019 - Taylor & Francis
Identifying the transition of relapsing-remitting multiple sclerosis (MS) to the secondary-
progressive MS form remains a clinical challenge due to the gradual nature of the transition …
progressive MS form remains a clinical challenge due to the gradual nature of the transition …
Secondary progressive multiple sclerosis: a review of clinical characteristics, definition, prognostic tools, and disease-modifying therapies
T Ziemssen, V Bhan, J Chataway, T Chitnis… - Neurology …, 2022 - AAN Enterprises
Many challenges exist in the precise diagnosis and clinical management of secondary
progressive multiple sclerosis (SPMS) because of the lack of definitive clinical, imaging …
progressive multiple sclerosis (SPMS) because of the lack of definitive clinical, imaging …
Diagnosing 'transition'to secondary progressive multiple sclerosis (SPMS): a step-by-step approach for clinicians
E Hamdy, F Talaat, I Ramadan, H Marouf… - Multiple Sclerosis and …, 2022 - Elsevier
Upon the approval of disease-modifying therapies (DMTs) for patients with active secondary
progressive phase of multiple sclerosis (SPMS), there became an emerging need to …
progressive phase of multiple sclerosis (SPMS), there became an emerging need to …
Therapeutic advances and challenges in the treatment of progressive multiple sclerosis
LE Baldassari, RJ Fox - Drugs, 2018 - Springer
Despite the fact that majority of patients with multiple sclerosis (MS) have relapsing-remitting
disease, many transition to secondary progressive disease (SPMS) over time. This transition …
disease, many transition to secondary progressive disease (SPMS) over time. This transition …
Progressive multiple sclerosis
L Amezcua - CONTINUUM: Lifelong Learning in Neurology, 2022 - journals.lww.com
PURPOSE OF REVIEW This article provides an update on progressive forms of multiple
sclerosis (MS) commonly referred to as primary progressive MS and secondary progressive …
sclerosis (MS) commonly referred to as primary progressive MS and secondary progressive …
Secondary progressive multiple sclerosis: new insights
In most cases, multiple sclerosis (MS) begins with a relapsing-remitting course followed by
insidious disability worsening that is independent from clinically apparent relapses and is …
insidious disability worsening that is independent from clinically apparent relapses and is …
Diagnosis and treatment of progressive multiple sclerosis: A position paper
C Pozzilli, M Pugliatti, P Vermersch… - European Journal of …, 2023 - Wiley Online Library
Abstract Background and Purpose Multiple sclerosis (MS) is an unpredictable disease
characterised by a highly variable disease onset and clinical course. Three main clinical …
characterised by a highly variable disease onset and clinical course. Three main clinical …
Relapsing and progressive forms of multiple sclerosis: insights from pathology
R Dutta, BD Trapp - Current opinion in neurology, 2014 - journals.lww.com
Available therapies for multiple sclerosis patients, while effective during the relapsing phase,
have little benefit for progressive multiple sclerosis patients. Development of therapies to …
have little benefit for progressive multiple sclerosis patients. Development of therapies to …
Secondary progressive multiple sclerosis: definition and measurement
D Plantone, F De Angelis, A Doshi, J Chataway - CNS drugs, 2016 - Springer
Secondary progressive multiple sclerosis (SPMS) is diagnosed retrospectively and involves
a clinical course characterized by a progressive accumulation of neurological disability …
a clinical course characterized by a progressive accumulation of neurological disability …
Progressive multiple sclerosis
Abstract Purpose of Review: Many therapeutic advances for relapsing-remitting multiple
sclerosis (MS) have occurred in the past 25 years. Although similar advances in disease …
sclerosis (MS) have occurred in the past 25 years. Although similar advances in disease …